21 July 2025
Ropes & Gray Advises Sanofi in Adagene Strategic Investment Up to $25 Million to Launch New SAFEbody Antibody Discovery Program
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ray Grant Lead | Ropes & Gray | Counsel | strategic transactions | Not stated |
| Dan Freshman | Ropes & Gray | Associate | strategic transactions | Not stated |
| Sam Tansley | Ropes & Gray | Associate | strategic transactions | Not stated |
| Abigail Gregor | Ropes & Gray | Partner | strategic transactions | Not stated |
| Tom Danielski | Ropes & Gray | Partner | strategic transactions | Not stated |
| Scott Pinarchick | Ropes & Gray | Partner | tax | Not stated |
| Elizabeth Whitkin | Ropes & Gray | Counsel | health care | Not stated |
| Derek Mubiru | Ropes & Gray | Associate | strategic transactions | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 25m (up to $25 million)
- What the figure measures
- Total transaction value
- Client
- SanofiInvestor
- Counterparties
- Adagene Inc. (Other)